Get the Stockscreener App
18.61
1.85%
-0.35
After Hours:
18.78
0.17
+0.91%
Arrowhead Pharmaceuticals Inc Stock (ARWR) Forecast
The Arrowhead Pharmaceuticals Inc (ARWR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $70.25, representing a +277.46% increase from the current price of $18.61. The highest analyst price target is $75.95, and the lowest is $64.54.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ARWR Price Target
Average 49.64
(+166.74% Upside)
Is Arrowhead Pharmaceuticals Inc (ARWR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 36.16 | Neutral |
| STOCH(9,6) | 8.4444 | Buy |
| STOCHRSI(14) | 4.2201 | Buy |
| MACD(12,26) | -0.7074 | Sell |
| ADX(14) | 20.34 | Neutral |
| William %R | -96.41 | Buy |
| CCI(14) | -77.33 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
20.04
Sell
|
19.96
Sell
|
| MA20 |
21.79
Sell
|
20.73
Sell
|
| MA50 |
21.04
Sell
|
21.12
Sell
|
| MA100 |
21.24
Sell
|
21.81
Sell
|
| MA200 |
23.45
Sell
|
23.46
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ARWR could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on ARWR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 36.16 indicates that ARWR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 8.4444 indicates that ARWR is oversold. This indicates that ARWR price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 4.2201 indicates that ARWR is oversold. This suggests that ARWR price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 20.34 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -77.33 indicates that ARWR is still oversold but not to an extreme extent.
Long-term ARWR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Arrowhead Pharmaceuticals Inc financial reports and earnings history, Arrowhead Pharmaceuticals Inc (ARWR) stock could reach $34.92 by 2030, $48.84 by 2040 and $69.25 by 2050. See the projected annual prices until 2050 of the Arrowhead Pharmaceuticals Inc stock below:
- Arrowhead Pharmaceuticals Inc (ARWR) is expected to reach an average price of $37.79 in 2035, with a high prediction of $38.37 and a low estimate of $31.52. This indicates an $103.08% rise from the last recorded price of $18.61.
- Arrowhead Pharmaceuticals Inc (ARWR) stock is projected to chart a bullish course in 2040, with an average price target of $48.17, representing an $158.86% surge from its current level. The forecast ranges from a conservative $37.38 to a sky-high $48.84.
- Our analysts predict Arrowhead Pharmaceuticals Inc (ARWR) to jump 159.67% by 2045, soaring from $46.29 to an average price of $48.32, potentially reaching $56.56. While $46.29 is the low estimate, the potential upside is significant.
- Arrowhead Pharmaceuticals Inc (ARWR) stock is expected to climb by 2050, reaching an average of $67.87, a $264.67% jump from its current level. However, a wide range of estimates exists, with high and low targets of $69.25 and $59.38, respectively, highlighting the market's uncertainty.
Arrowhead Pharmaceuticals Inc Stock (ARWR) Year by Year Forecast
Arrowhead Pharmaceuticals Inc Stock (ARWR) Price Forecast for 2025
Arrowhead Pharmaceuticals Inc Stock (ARWR) is expected to reach an average price of $49.64 in 2025, with a high prediction of $75.95 and a low estimate of $23.33. This indicates an +166.74% rise from the last recorded price of $18.61.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $65.41 | $64.54 | $75.95 | +251.48% |
| February, 2025 | $45.78 | $44.70 | $65.08 | +146.00% |
| March, 2025 | $38.07 | $37.48 | $50.22 | +104.54% |
| April, 2025 | $31.73 | $23.33 | $40.96 | +70.51% |
| May, 2025 | $42.84 | $29.61 | $43.84 | +130.21% |
| June, 2025 | $39.69 | $35.34 | $43.83 | +113.28% |
| July, 2025 | $40.59 | $34.68 | $42.80 | +118.13% |
| August, 2025 | $48.37 | $39.50 | $50.11 | +159.93% |
| September, 2025 | $44.10 | $43.43 | $55.87 | +136.98% |
| October, 2025 | $39.92 | $37.89 | $50.42 | +114.53% |
| November, 2025 | $46.95 | $36.75 | $57.01 | +152.30% |
| December, 2025 | $61.21 | $46.34 | $66.66 | +228.89% |
Arrowhead Pharmaceuticals Inc Stock (ARWR) Price Forecast for 2026
The predicted value for Arrowhead Pharmaceuticals Inc (ARWR) in 2026 is set at an average of $78.81. Estimates vary from a peak of $97.65 to a trough of $59.97, indicating an +323.47% surge from the present price of $18.61.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $66.91 | $59.97 | $76.41 | +259.51% |
| February, 2026 | $84.08 | $65.13 | $85.98 | +351.83% |
| March, 2026 | $84.67 | $74.04 | $90.68 | +354.99% |
| April, 2026 | $93.46 | $78.97 | $96.54 | +402.18% |
| May, 2026 | $71.36 | $66.94 | $93.32 | +283.43% |
| June, 2026 | $66.12 | $64.60 | $75.06 | +255.27% |
| July, 2026 | $76.81 | $64.49 | $81.25 | +312.72% |
| August, 2026 | $92.70 | $74.04 | $94.63 | +398.10% |
| September, 2026 | $71.14 | $64.00 | $97.65 | +282.26% |
| October, 2026 | $68.96 | $65.59 | $75.01 | +270.55% |
| November, 2026 | $71.14 | $61.93 | $72.42 | +282.26% |
| December, 2026 | $66.54 | $64.25 | $73.67 | +257.55% |
Arrowhead Pharmaceuticals Inc Stock (ARWR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Arrowhead Pharmaceuticals Inc (ARWR) is $59.91, with a high forecast of $88.88 and a low forecast of $30.94. This indicates an +221.92% increase from the last price of $18.61.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $70.07 | $61.97 | $71.98 | +276.52% |
| February, 2027 | $75.16 | $67.16 | $88.88 | +303.86% |
| March, 2027 | $73.72 | $67.51 | $78.83 | +296.14% |
| April, 2027 | $61.88 | $59.35 | $75.21 | +232.51% |
| May, 2027 | $53.83 | $50.76 | $60.54 | +189.25% |
| June, 2027 | $47.01 | $43.51 | $60.33 | +152.62% |
| July, 2027 | $50.09 | $42.99 | $52.86 | +169.17% |
| August, 2027 | $46.77 | $46.12 | $55.22 | +151.32% |
| September, 2027 | $38.32 | $31.99 | $48.72 | +105.93% |
| October, 2027 | $33.25 | $30.94 | $39.86 | +78.68% |
| November, 2027 | $45.87 | $33.75 | $47.59 | +146.49% |
| December, 2027 | $51.44 | $43.01 | $52.23 | +176.43% |
Arrowhead Pharmaceuticals Inc Stock (ARWR) Price Forecast for 2028
In 2028, Arrowhead Pharmaceuticals Inc (ARWR) is projected to reach an average price of $39.98, with a high projection of $52.64 and a low estimate of $27.33. This indicates an +114.85% rise from the last price of $18.61.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $43.58 | $41.58 | $52.64 | +134.20% |
| February, 2028 | $37.22 | $33.77 | $44.06 | +100.02% |
| March, 2028 | $39.00 | $34.20 | $40.13 | +109.54% |
| April, 2028 | $33.70 | $33.01 | $41.26 | +81.06% |
| May, 2028 | $42.51 | $31.95 | $42.99 | +128.41% |
| June, 2028 | $37.98 | $32.73 | $45.24 | +104.07% |
| July, 2028 | $37.35 | $36.29 | $41.93 | +100.68% |
| August, 2028 | $30.55 | $29.78 | $39.38 | +64.15% |
| September, 2028 | $30.42 | $27.33 | $32.11 | +63.45% |
| October, 2028 | $45.64 | $29.48 | $46.74 | +145.23% |
| November, 2028 | $40.32 | $36.62 | $45.62 | +116.65% |
| December, 2028 | $39.94 | $38.80 | $41.65 | +114.61% |
Arrowhead Pharmaceuticals Inc Stock (ARWR) Price Forecast for 2029
The 2029 price forecast for Arrowhead Pharmaceuticals Inc Stock (ARWR) is $34.55 on average, with a high prediction of $44.19 and a low estimate of $24.91. This represents an +85.64% increase from the previous price of $18.61.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $38.81 | $37.01 | $40.72 | +108.55% |
| February, 2029 | $32.21 | $31.13 | $38.75 | +73.08% |
| March, 2029 | $33.23 | $31.06 | $35.45 | +78.56% |
| April, 2029 | $30.92 | $27.76 | $33.36 | +66.14% |
| May, 2029 | $31.29 | $27.20 | $32.63 | +68.14% |
| June, 2029 | $27.51 | $25.01 | $34.04 | +47.83% |
| July, 2029 | $34.95 | $27.41 | $36.03 | +87.81% |
| August, 2029 | $36.46 | $34.00 | $44.19 | +95.93% |
| September, 2029 | $35.97 | $32.87 | $37.67 | +93.27% |
| October, 2029 | $31.59 | $31.38 | $41.10 | +69.77% |
| November, 2029 | $26.72 | $26.14 | $33.47 | +43.60% |
| December, 2029 | $26.87 | $24.91 | $29.08 | +44.38% |
Arrowhead Pharmaceuticals Inc Stock (ARWR) Price Forecast for 2030
Arrowhead Pharmaceuticals Inc Stock (ARWR) is expected to reach an average price of $53.06 in 2030, with a high forecast of $81.15 and a low forecast of $24.96. This signifies an +185.10% surge from the last price of $18.61.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $33.38 | $24.96 | $34.92 | +79.39% |
| February, 2030 | $34.61 | $33.12 | $36.14 | +85.99% |
| March, 2030 | $36.57 | $34.39 | $38.18 | +96.52% |
| April, 2030 | $41.45 | $35.01 | $44.23 | +122.74% |
| May, 2030 | $35.76 | $33.85 | $42.28 | +92.13% |
| June, 2030 | $46.01 | $34.63 | $47.61 | +147.26% |
| July, 2030 | $56.77 | $45.82 | $59.29 | +205.07% |
| August, 2030 | $71.75 | $60.13 | $81.15 | +285.53% |
| September, 2030 | $65.52 | $65.25 | $75.55 | +252.05% |
| October, 2030 | $48.94 | $47.76 | $65.79 | +162.98% |
| November, 2030 | $32.46 | $30.27 | $49.50 | +74.42% |
| December, 2030 | $33.55 | $27.15 | $39.85 | +80.27% |
1.76%
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):